Market Access/Reimbursement

Market access and reimbursement aligns clinical evidence, health economics, coding (CPT/HCPCS), and payer engagement to translate military medical innovations into reimbursable products. By generating real-world evidence, cost-effectiveness data, and regulatory/commercial pathways, it sustains trauma, infection-control, and prolonged field-care solutions for deployed forces.

Technical Challenges

  • Heterogeneous payer requirements across DoD, VA, TRICARE, and civilian insurers complicate coverage decisions

  • Limited randomized controlled trial data for battlefield interventions and devices in austere or prolonged-care settings

  • Gaps in procedure and device coding (CPT/HCPCS) for novel therapies impede billing and reimbursement

  • Difficulty capturing relevant clinical and economic outcomes in delayed-evacuation, polytrauma, and remote-care scenarios

Emerging Opportunities

  • Standardized combat-trauma registries and interoperable real-world evidence platforms

  • Early health-economic modelling tied to military use-cases (cost-effectiveness, budget-impact)

  • Rapid coding pathways or temporary codes for emergent devices, diagnostics, and procedures

  • Structured payer engagement frameworks tailored to expeditionary and prolonged-field-care deployment

Current and Emerging Technologies in Market Access/Reimbursement

Real-world evidence platforms & registries

Deployable registries and cloud-based RWE platforms that capture longitudinal combat-trauma outcomes, infection metrics, and device performance to support coverage decisions and post-market surveillance.

Health economic and value-assessment modeling

Cost-effectiveness, budget-impact, and decision-analytic models that quantify lifetime disability avoidance, readiness benefits, and downstream savings from hemorrhage control, infection prevention, and reconstructive therapies.

Coding, billing, and claims-management tools

Automated mapping to CPT/HCPCS, claims submission workflows, and temporary-code strategies to accelerate reimbursement for novel devices, diagnostics, and procedures used in field and fixed facilities.

Value-based contracting & outcomes-based agreements

Contracts that link payment to clinical outcomes, readiness metrics, or reduced long-term care costs—enabling payers to share risk and support rapid fielding of high-impact solutions.

Digital health reimbursement & telemedicine models

Reimbursement frameworks for remote monitoring, teleconsultation, and digital therapeutics that extend prolonged and distributed care into austere environments while documenting clinical value.

Importance to Military Medicine

Ensures deployed Warfighter access

Reimbursement enables procurement, sustainment, and routine use of life-saving technologies at point-of-injury and in forward treatment sites.

Supports prolonged and austere care

Value evidence drives adoption of telehealth, remote-monitoring, and modular devices critical during delayed evacuation and prolonged-field-care.

Preserves readiness and reduces long-term costs

Coverage decisions that reflect readiness and disability avoidance incentivize technologies that return Warfighters to duty and lower lifetime care burdens.

Accelerates fielding from prototype to practice

Market access planning integrated early in development shortens transition timelines for combat-relevant innovations.

Alignment with the MTEC Mission

Directly accelerates Warfighter benefit by linking clinical evidence to procurement and payer pathways.

Enables public–private partnerships consistent with MTEC’s mission to transition military-relevant technologies to real-world use.

Leverages dual-use civilian markets to expand evidence generation, scale manufacturing, and reduce costs.

Supports multidisciplinary teams—clinical, regulatory, economic, and contracting—central to MTEC-sponsored projects.

Dual-Use (Military + Civilian) Applications

Civilian uptake of military-proven technologies increases evidence volume, shortens payer acceptance timelines, and improves scale economies.

Shared regulatory and reimbursement strategies support biodefense and pandemic-response tools that serve both military and public health needs.

Value-based contracting lessons from civilian health systems inform DoD procurement models that reward readiness and long-term outcomes.

Dual-use reimbursement pathways encourage industry investment in ruggedized, deployable medical devices and diagnostics.

Explore MTEC Members with Market Access/Reimbursement Capabilities

MTEC members bring clinical trial networks, health-economics expertise, regulatory and coding specialists, and commercialization experience to bridge evidence-generation and payer adoption. Our consortium model convenes DoD stakeholders, industry, and academia to design studies, capture real-world outcomes, and negotiate procurement and reimbursement pathways. Explore member profiles to identify partners who accelerate deployment, scale manufacturing, and ensure that trauma, infection-control, and prolonged-care innovations reach the field.

66 Members with Market Access/Reimbursement capabilities.

Member
Advanced Regenerative Manufacturing Institute (ARMI)

The Advanced Regenerative Manufacturing Institute (ARMI) is a member-based, nonprofit organization dedicated to advancing the bioeconomy of the United States. Its mission encompasses enhancing manufacturing, healthcare, and education and workforce development, aiming to create a scalable and effective manufacturing ecosystem for engineered cells, tissues, and organs.

Member
MK Strategy Group

MK Strategy Group is a certified Service-Disabled Veteran-Owned Small Business (SDVOSB) and a leading government contractor specializing in innovative healthcare solutions for military, government, and commercial sectors. With over two decades of experience, the company excels in medical procurement and facility development. MK Strategy Group bridges the gap between medical technology providers and government agencies, offering tailored, turnkey solutions that accelerate success in the government market. Their approach combines military precision, deep industry expertise, and a commitment to quality, innovation, and financial stability—enabling them to manage large-scale, complex projects with efficiency and reliability.

Member
Deloitte

Deloitte is a leading global provider of audit, consulting, tax, and advisory services. The company is committed to improving public outcomes through a focus on people and developing relevant, timely, and sustainable solutions for clients. Deloitte's mission is to lead with purpose and drive positive change for people and communities, with a strong emphasis on social impact, sustainability, equity, and trust. Deloitte is also dedicated to helping the power, utilities, and renewables industry grow to become more sustainable, safe, and efficient, and is a fierce champion of industrials, inspiring optimism for the future.

Member
BioPharma Connections

BioPharma Connections is an independent, woman-owned consulting firm founded in San Francisco in 2007, providing strategic business development, technical operations, regulatory, product development, and commercialization support to the life sciences industry. Serving pharmaceutical, biotechnology, medical device, and diagnostic companies globally, the firm specializes in facilitating connections between organizations, service providers, CROs, CDMOs, and investors—guiding clients from concept to commercialization, with deep expertise in regulatory compliance, emerging technologies, and diverse therapeutic areas.

Member
SNIPR Biome

SNIPR Biome develops precision medicines for infections and diseases linked to antimicrobial resistance and microbiome dysbiosis, using CRISPR-based gene editing to selectively target pathogenic bacteria while sparing the rest of the microbial community. The company applies programmable CRISPR platforms, delivered by engineered phages or probiotics, to address difficult-to-treat infections and modulate the human microbiome. Its programs span discovery through Phase 2 clinical trials, with a significant patent portfolio supporting these innovations.

Member
International AIDS Vaccine Initiative (IAVI)

IAVI is a nonprofit scientific research organization dedicated to developing vaccines and antibodies for HIV, tuberculosis, and emerging infectious diseases. Their mission is to translate scientific discoveries into affordable, globally accessible public health solutions, aiming for a world where all people have equitable access to innovative vaccines and therapeutics.

Member
Ease Healthcare

Ease Healthcare (a registered DBA of MPS Medical, Inc.) is committed to advancing next-generation military medicine by accelerating access to clinically validated diagnostic tools, monitoring devices, and health and wellness technologies. As a trusted commercialization partner and distributor, the company empowers providers, organizations, and individuals with advanced solutions that support early detection, timely intervention, and improved health outcomes in both civilian and military settings. With a mission to make cutting-edge science and technology accessible to all, Ease Healthcare focuses on addressing critical health challenges such as 02 delivery, cancer, and cardiovascular disease —areas that directly impact force readiness and resilience. The company’s vision is to break barriers in healthcare by delivering innovative medical solutions that are affordable, accessible, and simple to use, regardless of economic or geographic limitations. In addition to bringing transformative technologies to market, Ease Healthcare provides turnkey services for medical device manufacturing and distribution, guiding partners from product development through regulatory compliance and successful deployment. By combining technical expertise with a dedication to accessibility, Ease Healthcare supports the Department of Defense’s priorities in preparing and protecting service members with next-generation healthcare solutions.

Member
EmergingDx

EmergingDx is dedicated to inventing, developing, and commercializing emerging technologies and products aimed at improving the quality of the human condition while positively impacting the environment and society. The company comprises a diverse team of world-class scientists, engineers, product designers, and business leaders with a proven track record of innovation and successful technology transition.

Member
PPD

PPD, a clinical research business of Thermo Fisher Scientific, is a leading provider of global contract research organization (CRO) solutions. The company is dedicated to helping clients accelerate the development of life-changing therapies through comprehensive drug development, laboratory, and lifecycle services. With a commitment to operational excellence and innovative technology, PPD empowers its customers to bring therapies to market faster and improve patient health. PPD has been recognized as an industry leader in clinical development digital transformation services and patient engagement digital transformation. With over 30 years of clinical leadership and a workforce of more than 30,000 employees globally, PPD has conducted over 2,100 trials in the past five years.

Member
Simbex

Simbex is a leading partner in medical device and consumer health product design and development, recognized for transforming complex ideas into commercially successful solutions. With a multidisciplinary team, Simbex excels in engineering, product design, software, data analytics, and commercialization strategy, supporting innovators from concept to market. Their mission is to deliver impactful medical devices and consumer health products that improve health outcomes and quality of life. Simbex is known for its holistic approach, deep regulatory expertise, and commitment to innovation and excellence in the health technology sector. The company is also active in thought leadership, regularly publishing regulatory and reimbursement updates, and hosting educational webinars for the MedTech community. Simbex maintains a robust Quality Management System compliant with ISO 13485 and FDA 21 CFR 820, ensuring high standards in product development. The company is also committed to supporting diversity in MedTech, including initiatives for women in the sector. Simbex's leadership and advisory team bring decades of experience in biomedical engineering, commercialization, regulatory affairs, and technology innovation, further strengthening its position as a trusted partner in the MedTech ecosystem.

Member
Martin, Blanck & Associates, LLC

Martin, Blanck & Associates, LLC (MBA) is a healthcare consulting firm based in Alexandria, Virginia, founded in 1998 by Dr. Edward Martin and Mr. Alfred Giambone. The firm specializes in providing critical assistance to private sector clients, nonprofits, associations, and universities focused on federal healthcare delivery systems, public health programs, and government contracting. With over two dozen senior executive partners and more than 500 years of combined healthcare experience, MBA offers expertise in healthcare policy, program development, executive management, strategic planning, informatics, medical countermeasures, public health strategies, and emerging infectious diseases. The firm is committed to professionalism, ethical service, and delivering results for clients in both the public and private sectors.

Member
Accenture

Accenture is a global professional services company with extensive capabilities in strategy and consulting, digital transformation, technology, and operations. The company aims to drive innovation and efficiency across various industries, helping clients navigate complex challenges and seize opportunities in a rapidly changing environment. Accenture is committed to creating positive change around the world and ensuring responsible business leadership for its people, clients, and communities. The company emphasizes continuous learning, responsible AI practices, and a culture of belonging and diversity.

Member
Smith+Nephew

Smith+Nephew is a portfolio medical technology company focused on the repair, regeneration, and replacement of soft and hard tissue. The company aims to restore people's bodies and their self-belief by using technology to take the limits off living. With a commitment to medical education and improving patient outcomes, Smith+Nephew operates in over 100 countries and is dedicated to sustainability and community health. Their purpose is to promote health and wellbeing, not just through their products but also by ensuring a positive impact on society and the environment. Smith+Nephew is also committed to increasing diversity within the medical device industry through initiatives like the Orthopaedics for All global advisory board.

Member
Flen Health

Flen Health develops, manufactures, and distributes advanced biotechnological solutions for wound and skin healing. Its offerings include topical dressings, gels, cleansers, and educational resources for both clinical professionals and patients. Operating globally in over 40 countries, Flen Health emphasizes research-driven product development, clinical education, and international collaboration to promote inclusive and effective wound care.

Member
Alira Health

Alira Health is a global consulting and clinical services company that aims to humanize healthcare and life sciences through innovative technologies and expert guidance. They focus on improving patient outcomes by integrating patient voices into the development of treatments and enhancing care quality across the healthcare ecosystem.

Member
New Horizon Medical Solutions

New Horizon Medical Solutions is a national advanced wound-care platform delivering biologics, devices, diagnostics, clinical education, reimbursement support, and operational infrastructure to outpatient, post-acute, surgical, and wound-care providers. The company partners with leading manufacturers and healthcare organizations to support compliant adoption of advanced wound-care technologies across the full care continuum.

We are here to help

Can’t find what you’re looking for?

Projects

Technology Showcase

See All Projects

SurgiBox Inc.

Rapidly Deployable, Sterile Surgical Environments for Prolonged Field Care: SurgiBox

SurgiBox is advancing SurgiField, a lightweight, rapidly deployable surgical environment designed to bring sterile, operating room-like conditions to austere and forward-deployed military settings. Through MTEC Award No. MTEC-24-01-MPAI-267, supported by the Defense Health Agency, SurgiBox is developing next-generation capabilities to accelerate deployment, improve casualty care, and expand access to lifesaving surgery when evacuation is delayed.

Circadian Positioning Systems

Circadian-Targeted Lighting to Reduce Fatigue-Driven Errors in 24/7 Naval Operations: Circadian Positioning Systems

Circadian Positioning Systems (CPS) is advancing personalized, circadian-targeted lighting to reduce fatigue-driven errors among sailors serving in 24/7 naval operations. Through MTEC Award No. MTEC-23-05-NMT-003, CPS is moving its technology from research and development into operational validation, assessing a tailored lighting system aboard an Arleigh Burke-class destroyer during an 11-month deployment.

Spectral AI

AI Powered Burn and Blast Wound Assessment for Combat Casualty Care: Spectral AI Inc.

With a $4.0 million MTEC award, Spectral AI is advancing a handheld, AI-powered diagnostic tool that builds on its FDA-cleared DeepView System to provide immediate, objective assessments of burn and blast wound healing potential. The MTEC-supported effort has progressed to a working prototype with potential to improve treatment decisions and military burn care.

University of Pittsburgh

High Resolution Optogenetic Therapy for Vision Restoration in Blinded Warfighters: University of Pittsburgh

MTEC-funded research at the University of Pittsburgh is advancing a promising approach to restoring vision in blinded Warfighters. Read how optogenetic therapy is bringing higher-resolution sight closer to reality.

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.